Farge, Dominique
Loisel, Séverine
Resche-Rigon, Matthieu
Lansiaux, Pauline
Colmegna, Ines
Langlais, David
Charles, Catney
Pugnet, Grégory
Maria, Alexandre Thibault Jacques
Chatelus, Emmanuel
Martin, Thierry
Hachulla, Eric
Kheav, Vissal David
Lambert, Nathalie C
Wang, HanChen
Michonneau, David
Martinaud, Christophe
Sensebé, Luc
Cras, Audrey
Tarte, Karin
This article is maintained by: Elsevier
Article Title: Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study
Journal Title: The Lancet Rheumatology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S2665-9913(21)00326-X
CrossRef DOI link to the associated document: https://doi.org/10.1016/S2665-9913(21)00388-X
Content Type: article
Copyright: © 2021 Elsevier Ltd. All rights reserved.